4

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: December 12, 2016
Period of Report: December 12, 2016
Accession Number: 0001213900-16-019329

View Document ↗ View on SEC.gov ↗